Israel Englander Insmed Inc Call Options Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$62.0 - $79.01 $1.06 Million - $1.35 Million
17,100 Added 18.94%
107,400 $7.84 Million
Q2 2024

Aug 14, 2024
BUY
$22.0 - $69.71 $1 Million - $3.18 Million
45,600 Added 102.01%
90,300 $6.05 Million
Q1 2024

May 15, 2024
BUY
$25.72 - $29.94 $1.15 Million - $1.34 Million
44,700 New
44,700 $1.21 Million

Others Institutions Holding INSM

# of Institutions
465
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email